Ilka Lopes Santoro

Ilka Lopes Santoro

Auto-generated profile, based on publicly available information

Ilka Lopes Santoro


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2016 in Immunotherapy
Verified
Journal Article
Closed access
PAPedro N Aguiar
Pedro N Aguiar
ISIlka Lopes Santoro
Ilka Lopes Santoro
HTHakaru Tadokoro
Hakaru Tadokoro
GLGilberto de Lima Lopes
Gilberto de Lima Lopes
BFBruno Andraus Filardi
Bruno Andraus Filardi
Ramon Andrade Bezerra De MelloRamon Andrade Bezerra De Mello
Ramon Andrade Bezerra De Mello
Background: Tumor programmed death ligand one (PD-L1) expression has been studied in several trials in non-small-cell lung cancer. Methods: We assessed the potential role of PD-L1 expression according to Cochrane Collaboration's Guidelines. Results: 13 studies with 1979 patients were included. Among 915 PD-L1 negative patients this rate was 13% (RR 2.08; 95% CI: 1.49–2.91; p < 0.01). The response rate has increased concurrent to the PD-L1 expression (Pearson's correlation, r = 0.43). PD-L1 expression was also related to better 24-weeks progression-free rate (RR 0.79; 95% CI: 0.71–0.89) and a trend toward better 1-year overall survival rate (RR 0.96; 95% CI: 0.87–1.06). Conclusion: Taking this data in account, PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.

23 January 2017 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
EBEliana Lourenço Borges
Eliana Lourenço Borges
JFJuliana Franceschini
Juliana Franceschini
LCLuiza Helena Degani Costa
Luiza Helena Degani Costa
AFAna Luisa Godoy Fernandes
Ana Luisa Godoy Fernandes
SJSérgio Jamnik
Sérgio Jamnik
ISIlka Lopes Santoro
Ilka Lopes Santoro
Objective: Patients with lung cancer experience different feelings and reactions, based on their family, social, cultural, and religious backgrounds, which are a source of great distress, not only for the patients but also for their family caregivers. This study aimed to evaluate the impact that lung cancer stage and quality of life (QoL) of lung cancer patients have on caregiver burden. Methods: This was a prospective cross-sectional study. Consecutive patient-caregiver dyads were selected and asked to complete the Hospital Anxiety and Depression Scale and the Medical Outcomes Study 36-item ShortForm Health Survey (SF-36). Family caregivers also completed the Caregiver Burden Scale. Group-based modeling was used in order to identify patients with early- or advanced-stage cancer (IA to IIIA vs. IIIB to IV) plus non-impaired or impaired QoL (SF36 total score > 50 vs. ≤ 50). Patient-caregiver dyads were stratified into four groups: early-stage cancer+non-impaired QoL; advanced-stage cancer+non-impaired QoL; early-stage cancer+impaired QoL; and advanced-stage cancer+impaired QoL. Results: We included 91 patient-caregiver dyads. The majority of the patients were male and heavy smokers. Family caregivers were younger and predominantly female. The burden, QoL, level of anxiety, and level of depression of caregivers were more affected by the QoL of the patients than by their lung cancer stage. The family caregivers of the patients with impaired QoL showed a higher median burden than did those of the patients with non-impaired QoL, regardless of disease stage. Conclusions: Caregiver burden is more affected by patient QoL than by lung cancer stage.

1 October 2013 in Sleep Medicine
Verified
Journal Article
Closed access
ICIvan Chérrez-Ojeda
Ivan Chérrez-Ojeda
DJDonna B. Jeffe
Donna B. Jeffe
TGThomas Guerrero
Thomas Guerrero
RMRonnie Mantilla
Ronnie Mantilla
ISIlka Santoro
Ilka Santoro
ACAnnia Cherrez
Annia Cherrez

1 February 2011 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
AVAline Arlindo Vieira
Aline Arlindo Vieira
ISIlka Lopes Santoro
Ilka Lopes Santoro
SDSamir Dracoulakis
Samir Dracoulakis
LCLilian Ballini Caetano
Lilian Ballini Caetano
AFAna Luisa Godoy Fernandes
Ana Luisa Godoy Fernandes
OBJETIVO: Existem evidências da associação entre asma e sintomas psiquiátricos e transtornos mentais. Essa associação pode resultar em dificuldades de se atingir o controle da asma. O objetivo deste estudo foi avaliar a associação de ansiedade e depressão com o controle da asma. MÉTODOS: Estudo transversal com 78 pacientes asmáticos com diagnóstico confirmado de asma moderada a grave e regularmente tratados no Ambulatório de Asma do Hospital São Paulo da Universidade Federal de São Paulo, São Paulo (SP). Os pacientes foram divididos em dois grupos em relação ao status de controle de asma, determinado através do teste de controle da asma, e, posteriormente, comparados em termos de dados demográficos, clínicos e espirométricos, escore do questionário de qualidade de vida para asma e escore da escala hospitalar de ansiedade e depressão. RESULTADOS: A maioria era do sexo feminino. Dos 78 pacientes, 49 (63%) foram classificados como tendo asma não controlada. A prevalência de ansiedade e do binômio ansiedade/depressão foi significantemente maior entre os pacientes não controlados do que nos controlados (78% e 100%; p = 0,04 e p = 0,02, respectivamente), enquanto nem prevalência de depressão, nem os dados espirométricos ou de qualidade de vida diferiram entre os grupos. CONCLUSÕES: Nesta amostra, os pacientes com asma não controlada apresentaram uma maior prevalência de sintomas de ansiedade que aqueles com asma controlada. Na avaliação de pacientes asmáticos, deve-se considerar o impacto negativo dos distúrbios de humor nas estratégias de controle da asma.

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
FHFernando Herbella
Fernando Herbella
SNSebastião Pannocchia Neto
Sebastião Pannocchia Neto
ISIlka Lopes Santoro
Ilka Lopes Santoro
LFLicia Caldas Figueiredo
Licia Caldas Figueiredo
The association of gastroesophageal reflux disease (GERD) and esophageal cancer is well known. The carcinogenic properties of the gastroduodenal contents may also lead to cancer in target organs for GERD especially considering that they do not have intrinsic protective mechanisms as found in the esophagus. This review focuses on the putative relation between GERD and non-esophageal cancer. Most of the papers reviewed are far from ideal to prove the relationship of extra-esophageal cancer and GERD since a small number of patients is presented, most do not control cases based on tobacco usage and obesity, and the diagnosis of GERD is variable, not always from an objective measurement such as pH monitoring but relying on symptoms in most reports. Nevertheless, head and neck and lung cancer have a growing incidence parallel to GERD and a shift towards non-smoking, female gender and adenocarcinoma (compared to squamous cell carcinoma) is arising, similar to the example of esophageal cancer with the exception of the female gender.

6 May 2010 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
MAM. M. Amorim
M. M. Amorim
AAA. Araruna
A. Araruna
LCL. B. Caetano
L. B. Caetano
ACA. C. Cruz
A. C. Cruz
LSL. L. Santoro
L. L. Santoro
AFAna Luisa Godoy Fernandes
Ana Luisa Godoy Fernandes